.png
)
CDSCO Circular New Drugs Division NDCT Rules 2019 Formulation Intermediates Modified Release 24 June 2026 ⚠ Regulatory Action — Immediate Attention Required All manufacturers and importers of formulation intermediates including SR/ER/PR/DR pellets, directly compressible granules, taste-masked granules, and modified release…
⚡ Breaking · Gazette Extraordinary, June 15, 2026 | Immediate Effect Regulatory Action Centre Bans 16 Fixed Dose Combinations Under Section 26A of Drugs & Cosmetics Act The Ministry of Health and Family Welfare has prohibited the manufacture, sale and…
⚠ Regulatory Alert Drug residues in shrimp exports have triggered a sweeping directive from CDSCO, putting state drug controllers on notice to act — or face more international trade fallout. India's Central Drugs Standard Control Organization (CDSCO) has…
4th June, 2026 Drugs Controller General of India (DCGI), issued a formal circular directing all drug manufacturers and all stakeholders to ensure they have a working pharmacovigilance (PV) system in place — one that is fully compliant with the Drugs…
The Ministry of Health and Family Welfare has formally added the widely used nerve-pain drug Pregabalin to Schedule H1 of the Drugs Rules, 1945 — a category reserved for substances with high abuse potential. The Government of India has officially…